ArticleEvidence-based dentistry2026
Can dentists recognise the hidden burden of Sjögren disease beyond xerostomia?
Article in Evidence-based dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
a commentary onLee AYS, Zembrzuska H, Franke KB, Gordon R, Franke EF, Kumble L, Boderman B, Pelkas C, Hitchcock ME, Cornec D, Rischmueller M, Bowman SJ, Seror R, McCoy SS, DiRenzo D. Patients' perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group. Semin Arthritis Rheum. 2026;77:152929 https://doi.org/10.1016/j.semarthrit.2026.152929
designSystematic review with thematic synthesis of qualitative studies conducted in accordance with PRISMA guidelines to synthesise the lived experiences of adults with Sjögren disease. CASE SELECTION: MEDLINE (via PubMed), Embase and the Cochrane Library were searched for English-language studies published between July 2002 and July 2024. Eligible studies included adults (≥18 years) diagnosed with Sjögren disease according to the 2002 American-European Consensus Group or the 2016 ACR/EULAR classification criteria and explored patients' lived experiences using qualitative interviews or focus groups. Quantitative (survey) studies, case reports and conference abstracts were excluded. DATA ANALYSIS: Two reviewers independently screened studies and extracted data. Methodological quality of the included studies was independently assessed using the Critical Appraisal Skills Programme (CASP) Qualitative Checklist and the Walsh-Downe criteria. Primary qualitative data underwent line-by-line coding followed by thematic synthesis using the Thomas and Harden approach to generate descriptive categories and overarching analytical themes.
resultsNine qualitative studies involving 162 participants from ten countries met the inclusion criteria. Five overarching themes characterised patients' experiences: the invisible and unpredictable nature of symptoms; coping and adaptation strategies; impaired social, occupational and interpersonal functioning; challenges navigating healthcare systems; and varying perceptions of disease and treatment. Persistent oral and ocular dryness, fatigue and pain were consistently associated with reduced quality of life, while delayed diagnosis, inadequate disease awareness and feelings of dismissal by healthcare professionals emerged as recurrent concerns.
conclusionsThe lived experience of Sjögren disease extends well beyond sicca symptoms and encompasses substantial physical, emotional and social burdens. Integrating patients' perspectives into clinical care and outcome assessment may facilitate more patient-centred management and improve the relevance of future clinical research.
Identifiers
42786284What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.